[{"id":"9308754f-0181-4ad9-a87a-c836e3b1830b","acronym":"","url":"https://clinicaltrials.gov/study/NCT01992042","created_at":"2023-01-20T14:59:27.585Z","updated_at":"2024-07-02T16:37:16.821Z","phase":"Phase 2","brief_title":"Novel Window of Opportunity Trial to Evaluate the Impact of Statins to Oppose Prostate Cancer","source_id_and_acronym":"NCT01992042","lead_sponsor":"University Health Network, Toronto","biomarkers":" RAP1A","pipe":"","alterations":" ","tags":["RAP1A"],"overall_status":"Completed","enrollment":" Enrollment 33","initiation":"Initiation: 02/01/2014","start_date":" 02/01/2014","primary_txt":" Primary completion: 10/01/2016","primary_completion_date":" 10/01/2016","study_txt":" Completion: 12/01/2016","study_completion_date":" 12/01/2016","last_update_posted":"2017-10-26"}]